A Phase 1, Randomized, Open-Label Study in Healthy Adult Male Subjects to Assess the Pharmacokinetics and Pharmacodynamics of RDEA3170

Trial Profile

A Phase 1, Randomized, Open-Label Study in Healthy Adult Male Subjects to Assess the Pharmacokinetics and Pharmacodynamics of RDEA3170

Completed
Phase of Trial: Phase I

Latest Information Update: 15 Sep 2016

At a glance

  • Drugs Verinurad (Primary)
  • Indications Gout
  • Focus Pharmacodynamics; Pharmacokinetics
  • Sponsors Ardea Biosciences
  • Most Recent Events

    • 31 Aug 2016 Status changed from not yet recruiting to completed.
    • 25 Nov 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top